Search

everythinglearnresearchcommunity

for

Search:↓

The study found new details about human hair growth and suggests that preventing a specific biological pathway could potentially treat hair graying.

Wnt activation shows promise for regenerative medicine but requires selective targeting to minimize risks like cancer.

Pangolins have lost some skin-related genes, but kept others, showing complex skin evolution.

Formyl-peptide receptor agonists could be new anti-inflammatory drugs.

Different scaffold patterns improve wound healing and immune response in mouse skin, with aligned patterns being particularly effective.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Applying a special DNA plasmid to the skin can make it thicker and stronger.

The document concludes that more research is needed to fully understand the causes of PCOS.

Pantethine may boost the immune system's ability to fight sarcoma.

A gene called APCDD1, which controls hair growth, is found to be faulty in a type of hair loss called hereditary hypotrichosis simplex.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

Celsr1 is crucial for skin cell alignment, while Celsr2 has little effect on this process.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

The document concludes that stem cells and their environments are crucial for skin and hair health and have potential for medical treatments.

New treatments for hair loss may target specific pathways and generate new hair follicles.

MicroRNA-205 helps hair grow by changing the stiffness and contraction of hair follicle cells.

Immune cells in Hidradenitis suppurativa become more inflammatory and may be important for treatment targets.

New acne treatments include combination creams, advanced retinoids, and light therapies, focusing on safety and patient adherence.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

Advanced therapies like gene, cell, and tissue engineering show promise for hair regrowth in alopecia, but their safety and effectiveness need more verification.

FLCN helps control iron levels in cells.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

Muscles and nerves that cause goosebumps also help control hair growth.

Immune cells help regulate hair growth, and better understanding this can improve hair loss treatments.

EGFR helps control how hair grows and forms without needing p53 protein.

Involucrin gene expression is controlled by specific proteins and signaling pathways.

Notch signaling is essential for healthy skin and hair follicle maintenance.

Mutations in the glucocorticoid receptor gene cause reduced sensitivity to glucocorticoids and may lead to poor response to treatment.

Androgenetic alopecia is mainly caused by genetic factors and increased androgen activity, leading to hair follicle miniaturization.

Researchers identified five new potential targets for leishmaniasis treatment, suggesting repurposing existing drugs could be effective.